Jack Henry & Associates, Inc. JKHY
Verdict: Sell. Fair value $142 against a price of $181 on 6 Jan 2026, 22% below the price.
In plain words
The case for: Narrow competitive moat provides durability. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins.
Main risks
- Incomplete balance sheet data (Total Debt is 'nan'), which forces assumptions in key return metrics like ROIC and ROIIC.
- Significant Free Cash Flow volatility, with a sharp drop to $0.17B in 2023 from $0.31B in 2022, raising questions about cash conversion consistency.
- Limited near-term upside based on analyst consensus price targets (+3.7% to mean), suggesting the stock may be fully valued.
- Intense competitive environment
- Valuation prices in optimistic scenario (limited margin for error)